par Kenis, Yvon ;Rozencweig, Marcel
Référence Acta Tuberculosea et Pneumologica Belgica, 66, 4-5, page (368-379)
Publication Publié, 1975
Article révisé par les pairs
Résumé : Single agent chemotherapy of advanced lung cancer is still unsatisfactory. The most encouraging results have been obtained with high dose intermittent treatment with cyclophosphamide, methotrexate or adriamycin. Combination chemotherapy is probably more efficacious than single agent chemotherapy, especially in oat cell carcinoma. The best treatment schedules give a response rate of approximately 80%. The value of adjuvant chemotherapy is not yet established, but new controlled clinical trials are indicated considering the poor results achieved by surgery and radiotherapy.